Inflammation is implicated in several medical conditions that are sexually dimorphic, including depression, cardiovascular diseases, autoimmunity, and presumably cancer progression. Here we studied the effects of the proinflammatory agent, LPS, on MADB106 lung tumor retention (LTR), and sought to elucidate underlying mechanisms and sexual dimorphism. F344 male and female rats were administered with LPS (0.001-1 mg/kg i.v.) simultaneously with tumor cell inoculation, and treated with a b-blocker (nadolol, 0.2-0.3 mg/kg s.c.), a COX inhibitor (indomethacin, 4 mg/kg s.c.) or both drugs. To study the role of NK cells, numbers and cytotoxicity of marginating-pulmonary NK cells were studied, and selective in vivo NK-depletion was employed. Serum levels of corticosterone, IL-6, and TNF-a were also assessed. The findings indicated that LPS increased LTR in both sexes, but 10-fold higher doses were needed in females to reach the increase evident in males. Additionally, nadolol and indomethacin reduced the effects of LPS, more so in males. In vivo NK-depletion and ex vivo NK activity studies suggested that LPS affected LTR through both NK-independent and NKdependent mechanisms, the latter mediated through prostaglandin release in males. Corticosterone, IL-6, and TNF-a responses to LPS were sexually dimorphic, but were not associated with LPS or drugs' impacts on LTR. Overall, our findings demonstrate sexual dimorphism in LPS-induced elevated susceptibility to MADB106 experimental metastasis, and in potential humoral underlying mechanisms. Further studies are needed to elucidate additional immunological and non-immunological mediators of these dimorphisms, as well as to assess their involvement in other sexually dimorphic pathologies that are associated with inflammation.
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Introduction
Several lines of evidence indicate sexual dimorphism in the course of human diseases, specifically in pathologies that are associated with inflammatory immune responses. Men are in a higher risk bracket for cardiovascular and infectious diseases (Klein, 2000; Marriott and Huet-Hudson, 2006; Schroder et al., 1998; Thom et al., 2006; Thorvaldsen et al., 1995) , show lower rates of depression and autoimmune diseases (Grigoriadis and Robinson, 2007; Kuehner, 2003; Whitacre, 2001) , and a differential rates of allergies, which are age and type specific (Almqvist et al., 2008; DunnGalvin et al., 2006; Schafer et al., 2001) . It is noteworthy that inflammatory responses have been proposed to play a role in the etiology, progression, or prognosis of each of these pathological conditions (for cardiovascular and infectious disease Elkind, 2006; Lindsberg and Grau, 2003; Poulin, 1996; Ross, 1999; Wang et al., 2007) (for depression and autoimmune diseases Dantzer et al., 2008; Raison et al., 2006; Tincani et al., 2007) (for allergies Averbeck et al., 2007; Tsitoura and Tassios, 2006) . Cancer progression is believed to be associated with inflammation and to show sexual dimorphism, but the evidence is ambiguous (see Section 4).
Several immune responses, including inflammation, are believed to be sexually dimorphic in humans. Studies suggested that women mount a stronger immune responses to a variety of antigens (Da Silva, 1995; Verthelyi, 2001) , and others studies demonstrated that men suffer from higher rates of sepsis and septic shock (Moss, 2005; Wichmann et al., 2000) , including higher circulating levels of the proinflammatory TNF-a, and lower levels of the anti-inflammatory IL-10 (Schroder et al., 1998) . In agreement with the latter findings, menopause is associated with an increase in the levels of proinflammatory cytokines, including IL-1, IL-6, and TNF-a (Pfeilschifter et al., 2002) . Sex-based differences were also shown in vitro following human leukocytes exposure to LPS (Marriott and HuetHudson, 2006) . LPS, a component of the outer cell wall of gram-negative bacteria, is extensively used in studying systemic inflammatory re- 
